Addleshaw Goddard appoints commercial litigation expert Bill Gilliam
Addleshaw Goddard has announced the arrival of commercial litigation expert Bill Gilliam, previously head of Eversheds’ health and life sciences practice.
According to the firm, the hire is part of a strategy to strengthen the firm’s core offering in Leeds as well as investing in its capability to handle large complex disputes in the healthcare sector in particular, and also in the IT, public and public procurement sectors.
Gilliam has experience acting for FTSE 100 clients, public sector bodies and especially health and pharma companies on a range of high-value and high-profile disputes.
He has extensive experience in healthcare including a secondment as acting head of legal in the commercial directorate of the Department of Health and he is also a well-known and respected practitioner in the local Yorkshire market.
Gilliam is noted in the Legal 500 as providing ‘expert advice that is appropriate and practical’ and in Chambers as being ‘praised for his extensive litigation experience’ and for being ‘bright and pragmatic’.
News from Addleshaw Goddard
News from The Lawyer
Briefings from Addleshaw Goddard
The Court of Appeal has overturned a High Court judge’s decision to add words to a non-compete restriction, which had originally offered the employer very little protection.
Relaxation of information and consultation requirements for micro-employers for transfers taking place on or after 31 July 2014
Regulation 13 of TUPE 2006 obliges employers to inform and consult with ‘appropriate representatives’ of the employees who are affected by the transfer.
Analysis from The Lawyer
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?
The past five years have not been easy for Addleshaw Goddard. The firm’s revenue fell 7 per cent from £173.1m to £161.9m between 2008/09 and 2010/11 and despite finances looking up in 2011/12, when Addleshaws reported a 30 per cent increase in net profit, it has shown no notable compound growth in turnover since 2007/08.